Evidence map›Paper›PMID 18456797›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2008

Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5.

Qing Lu

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Signaling pathways and targeted therapy for pulmonary hypertension.Signal transduction and targeted therapy · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Pulmonary Endothelial Cell Apoptosis in Emphysema and Acute Lung Injury.Advances in anatomy, embryology, and cell biology · 2018
    Review
  8. Review
  9. Article
  10. Signaling by TGF-betas in tubule cultures of adult rat testis.American journal of translational research · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Alterations in molecular chaperones and eIF2alpha during lung endothelial cell apoptosis.American journal of physiology. Lung cellular and molecular physiology · 2010
    Article
  18. Transforming growth factor-beta1 causes pulmonary microvascular endothelial cell apoptosis via ALK5.American journal of physiology. Lung cellular and molecular physiology · 2009
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Qing LuVascular Research Laboratory, Providence Veterans Affairs Medical Center, Providence, Rhode Island 02908, USA. Qing_Lu@brown.edu
Providence VA Medical Center · US

Funding

Endothelial Barrier Function Modulation by PKCDeltaR01HL067795 · NHLBI · BROWN UNIVERSITY · PI HARRINGTON, ELIZABETH O · 2001 to 2011
$3.0M
Small GTPases and Lung Endothelial ApoptosisR01HL064936 · NHLBI · BROWN UNIVERSITY · PI ROUNDS, SHARON IRENE SMITH · 2000 to 2009
$2.5M
NHLBI NIH HHS HL-64936NHLBI NIH HHS HL-67795NHLBI NIH HHS R01 HL064936
6 · The paper itself

Abstract

Transforming growth factor (TGF)-beta1 has been reported to cause endothelial cell apoptosis. However, conflicting data have also demonstrated that TGF-beta1 promotes endothelial cell survival. In this study, the effect of TGF-beta1 on apoptosis of cultured bovine pulmonary artery endothelial cells (PAEC) induced by multiple stimuli was investigated. TGF-beta1 protected against apoptosis of bovine PAEC induced by serum deprivation or the VEGF receptor inhibitor SU-5416, but not by UV light exposure or TNFalpha. Neither caspase-8 nor caspase-12 was activated by serum deprivation or the VEGF receptor blocker. However, blockade of VEGF receptors activated caspase-9, an effect that was abolished by TGF-beta1. Furthermore, serum deprivation and inhibition of VEGF receptors significantly decreased the protein level of Bcl-2, an effect that was also abrogated by TGF-beta1. In addition, the baseline level of Bcl-2 was enhanced by TGF-beta1 and reduced by inhibition of activin receptor-like kinase 5 (ALK5), a TGF-beta1 type I receptor. Furthermore, inhibition of ALK5 caused apoptosis of bovine PAEC. These results suggest that TGF-beta1 signaling is critical for maintenance of bovine PAEC survival. Finally, the protective effects of TGF-beta1 on bovine PAEC apoptosis and Bcl-2 reduction were abolished by ALK5 inhibition, but not by inhibition of non-SMAD signaling pathways. Also, TGF-beta1 activated SMAD2 and SMAD1/5, an effect that was abolished by ALK5 inhibition. The results of this study suggest that TGF-beta1 protects against bovine PAEC apoptosis, possibly through ALK5-mediated Bcl-2 induction and subsequent inhibition of the mitochondria-mediated intrinsic pathway of apoptosis. Understanding the mechanism by which TGF-beta1 promotes endothelial cell survival may provide a better treatment for apoptosis-dependent vascular diseases, such as emphysema.

Indexed as

AnimalsApoptosisCaspase 12Caspase 8CattleCell SurvivalEmphysemaEndothelial CellsEnzyme ActivationHumansIndolesMitochondriaProtein Kinase InhibitorsProtein Serine-Threonine KinasesProto-Oncogene Proteins c-bcl-2Pulmonary ArteryCaspase 12Caspase 8IndolesProtein Kinase InhibitorsProtein Serine-Threonine KinasesProto-Oncogene Proteins c-bcl-2PyrrolesReceptors, Transforming Growth Factor betaReceptors, Vascular Endothelial Growth FactorReceptor, Transforming Growth Factor-beta Type ISemaxinibSmad ProteinsTGFBR1 protein, humanTransforming Growth Factor beta1Tumor Necrosis Factor-alpha

Identifiers

PMID18456797
PMCPMC2494777
OpenAlexW2118539012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.